Back to Screener

LENSAR, Inc. Common Stock (LNSR)

Price$5.60
Value ScoreA
Growth ScoreC
Momentum ScoreF

Favorite Metrics

Price vs S&P 500 (26W)-52.92%
Price vs S&P 500 (4W)-0.70%
VGM Score47.98
Market Capitalization$67.78M

All Metrics

Book Value / Share (Quarterly)$2.03
P/TBV (Annual)8.73x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)18.23%
Cash Flow / Share (Quarterly)$-1.01
Price vs S&P 500 (YTD)-60.01%
Gross Margin (TTM)45.71%
Net Profit Margin (TTM)50.94%
EPS (TTM)$1.78
10-Day Avg Trading Volume0.04M
EPS Excl Extra (TTM)$1.78
Revenue Growth (5Y)17.24%
EPS (Annual)$-2.87
ROI (Annual)-165.28%
Gross Margin (Annual)46.41%
Net Profit Margin (5Y Avg)-52.93%
Cash / Share (Quarterly)$1.12
P/E Basic Excl Extra (TTM)2.31x
Revenue Growth QoQ (YoY)-5.16%
ROA (Last FY)-47.58%
Revenue Growth TTM (YoY)1.12%
EBITD / Share (TTM)$-0.44
ROE (5Y Avg)-61.69%
Operating Margin (TTM)-11.35%
Cash Flow / Share (Annual)$-0.20
P/B Ratio2.76x
P/B Ratio (Quarterly)2.93x
Net Income / Employee (Annual)$-228,500
EV / Revenue (TTM)1.04x
Net Interest Coverage (TTM)-14.33x
ROA (TTM)42.26%
EV / EBITDA (TTM)2.23x
EPS Incl Extra (Annual)$-2.87
Current Ratio (Annual)2.80x
Quick Ratio (Quarterly)1.05x
3-Month Avg Trading Volume0.10M
52-Week Price Return-57.12%
P/E Incl Extra (TTM)2.31x
Revenue / Employee (TTM)$384,700
Tangible BV / Share (Quarterly)$1.62
P/S Ratio (Annual)1.16x
Asset Turnover (Annual)0.81x
52-Week High$13.67
Operating Margin (5Y Avg)-41.02%
EPS Excl Extra (Annual)$-2.87
CapEx CAGR (5Y)-25.84%
26-Week Price Return-44.99%
Quick Ratio (Annual)1.97x
13-Week Price Return-54.14%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)2.38x
Enterprise Value$60.29M
Revenue / Share Growth (5Y)-3.07%
Asset Turnover (TTM)0.83x
Revenue / Employee (Annual)$389,600
Inventory Turnover (Annual)2.05x
Pretax Margin (Annual)-58.66%
Cash / Share (Annual)$1.83
3-Month Return Std Dev89.45%
Gross Margin (5Y Avg)50.60%
Net Income / Employee (TTM)$196,000
ROE (Last FY)-165.28%
EPS Basic Excl Extra (Annual)$-2.87
Receivables Turnover (TTM)9.80x
Total Debt / Equity (Quarterly)0.20x
EPS Incl Extra (TTM)$1.78
Receivables Turnover (Annual)7.65x
ROI (TTM)122.85%
P/S Ratio (TTM)1.17x
Pretax Margin (5Y Avg)-52.93%
Revenue / Share (Annual)$4.89
Tangible BV / Share (Annual)$0.99
Forward P/E16.30x
Price vs S&P 500 (52W)-81.49%
P/E Ratio (TTM)2.31x
Year-to-Date Return-51.85%
5-Day Price Return-1.23%
EPS Normalized (Annual)$-2.87
ROA (5Y Avg)-31.65%
Net Profit Margin (Annual)-58.66%
Month-to-Date Return-3.45%
Cash Flow / Share (TTM)$-0.87
EBITD / Share (Annual)$-1.98
Operating Margin (Annual)-42.06%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-61.69%
P/E Excl Extra (TTM)2.31x
LT Debt / Equity (Quarterly)0.20x
EPS Basic Excl Extra (TTM)$1.78
P/TBV (Quarterly)3.68x
P/B Ratio (Annual)5.77x
Inventory Turnover (TTM)1.63x
Pretax Margin (TTM)50.94%
Book Value / Share (Annual)$1.50
Price vs S&P 500 (13W)-62.39%
Beta0.88x
Revenue / Share (TTM)$3.74
ROE (TTM)147.85%
52-Week Low$5.06
vGradeA
gGradeC
mGradeF
vgmGradeC
Show chart for

Earnings Surprise History

Q1 260.00est. 0.19

Analyst Recommendations

Mar 2026
Apr 2026
May 2026
Jun 2026
2.29
4.29
4.25
4.25

Industry Peers — Surgical & Medical Instruments(138)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
LNSRLENSAR, Inc. Common Stock
ACF$5.60
SYKStryker CorporationCCC$305.66
MMM3M CompanyCFC$153.76
BSXBoston Scientific Corp.CBD$48.55
MDLNMedline Inc. Class A common stockCDD$33.61
BDXBecton, Dickinson and Co.BCC$151.16
RMDResMed Inc.CBC$196.04
DXCMDexCom, Inc.CBC$72.86
WSTWest Pharmaceutical Services, Inc.DCB$314.50
SOLVSolventum CorporationCDB$81.01
PENPenumbra, Inc.FCB$320.53

About

LENSAR Inc develops and commercializes femtosecond laser systems for cataract surgery. The company's proprietary technology platform provides surgeons with advanced imaging, simplified procedure planning, and precision capabilities to enhance surgical outcomes and procedural efficiency. LENSAR generates revenue through its core laser system and associated consumable components, creating a recurring revenue model.